-
Your shopping cart is empty!
Schizophrenia: Paliperidone Extended-Release Tablets are indicated for the treatment of schizophrenia
The efficacy of Paliperidone in schizophrenia was established in three 6-week trials in adults and one 6-week trial in adolescents, as well as one maintenance trial in adults.
Schizoaffective Disorder: Paliperidone Extended-Release Tablets are indicated for the treatment of schizoaffective disorder as monotherapy and an adjunct to mood stabilizers and/or antidepressant therapy
The efficacy of Paliperidone in schizoaffective disorder was established in two 6-week trials in adults.
There are no products to list in this category.